News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
153 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2347)
Day
1 (247)
2 (153)
3 (119)
4 (61)
7 (125)
8 (120)
9 (108)
10 (98)
11 (60)
13 (8)
14 (122)
15 (104)
16 (130)
17 (119)
18 (31)
21 (89)
22 (113)
23 (192)
24 (172)
25 (121)
28 (196)
29 (201)
30 (224)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
1
2
3
4
7
8
9
10
11
13
14
15
16
17
18
21
22
23
24
25
28
29
30
FDA
FDA Job Cuts, Key Departures Bring ‘Revolving Door’ Debate Front and Center
With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, there could be a wealth of talent available to biopharma companies. Does this pose an ethical quandary? It depends on who you ask.
April 2, 2025
·
6 min read
·
Heather McKenzie
Government
Drugmakers Ask Trump for Staggered Tariffs as ‘Liberation Day’ Arrives
Trump has repeatedly called April 2 “Liberation Day,” alluding to a more sweeping and aggressive set of tariffs. Leerink Partners analysts said that the risks from Trump’s tariffs on the biopharma industry are “underappreciated.”
April 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
April 2, 2025
·
2 min read
Press Releases
Attralus Presents New Data on Its Pan-Amyloid Diagnostic Candidates at the 2025 American College of Cardiology (ACC) Annual Scientific Session
April 2, 2025
·
9 min read
Press Releases
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
April 2, 2025
·
11 min read
Press Releases
Codexis Appoints Cynthia Collins to Board of Directors
April 2, 2025
·
5 min read
Press Releases
Context Therapeutics to Participate in Upcoming Investor Conferences - April 1, 2025
April 2, 2025
·
2 min read
Press Releases
Evaxion announces business update and full year 2024 financial results
April 2, 2025
·
13 min read
Press Releases
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
·
1 min read
Press Releases
Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
April 2, 2025
·
9 min read
Previous
2 of 16
Next